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surrogates of six hysterectomized women became pregnant, 
while five did so (one surrogate became pregnant twice) for 
the Rokitansky syndrome patient group. 
Outcome parameters of the study population 
Variables Rokitansky Hysterectomized 
syndrome (n = 6) (n = 16) 
Mean patient age (range) (years) 30.8 (27-35) 38.8 (33-46) 
Mean age of surrogate (range) 33.8 (29-39) 29.4 (23-39) 
(years) 
Mean no. of oocytes retrieved 13.7 (4--40) 8.5 (1-22) 
(range) 
No. of cycles started 12IVF, 3 FER 21 IVF, 1 FER 
(reached oocyte retrieval) (12 IVF) (18 IVF) 
No. of cycles reaching embryo 11 IVF, 3 FER 16 IVF, 1 FER 
transfer 
Fertilization rate (%) 68.3 65.0 
Mean no. of embryos transferred 2.9 (6.0) 2.4 (2.2) 
(and cryopreserved) 
No. of pregnancies per embryo 6/14 (43) 6/17 (35) 
transfer (%) 
No. of miscarriages 3 2 
No. of babies Twins 1; Twins 3; 
singletons 1; singletons 1 
ongoing 1 
FER = frozen embryo replacement. 
Conclusion: Gestational surrogacy is a viable treatment option 
for these females. Patients with Rokitansky syndrome seem to 
have a better outcome than hysterectomized women. This may 
be related to their younger age. It is also possible that 
hysterectomy accelerates ovarian senescence. 
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Introduction: The majority of IVF centres are currently using 
a solution of polyvinylpyrrolidone (PVP) for the successful 
achievement of ICS!. To avoid introducing such a potentially 
harmful agent into the oocyte, we have developed a PVP-free 
ICSI procedure. 
Materials and methods: A total of 283 patients were treated 
with ICSI between July 1995 and December 1996. Sperm 
defects consisted of a low sperm count (10.46 ± 12.96X 106/ml; 
range 1 X 10-4-80) and severe asthenozoospermia (percentage 
progressive motility 8.10 ± 7.30%; range 0-40) associated 
with severe teratozoospermia (percentage abnormal forms 
85.83 ± 14.81%; range 60-95). Multifollicular induction, 
oocyte retrieval and sperm sample preparation were conducted 
as described previously (Jean et a!., 1992). Denuded oocytes 
to be injected were transferred one after another with 5 11 
sperm suspension in a 0.4 ml drop of fresh B2 medium onto 
the lid of a Nunclon four-well dish and then placed under an 
inverted microscope fitted with two manipulators. The motile 
selected spermatozoon was immobilized by lowering the injec-
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tion pipette and pressing the tail against the bottom of the lid 
until it stopped moving. Once immobilized, the spermatozoon 
was sucked, tail first, into the pipette and then injected into 
the oocyte using the smallest possible volume of B2 medium. 
Results: The overall results of our ICSI programme are 
summarized below. 
Results of PVP-free ICSI at our IVF centre 
Origin of the spermatozoon Total 
No. of cycles 
(oocytes collection) 
No. oocytes injected 
No. of intact oocytes 
No. of oocytes fertilized 
(2PN) 
Fertilization rate (%) 
No. of embryo transfers 
Embryo transfer rate per 
cycle (%) 
No. of pregnancies 
(/3-HCG positive) 
Pregnancy rate per 
cycle (%) 
Pregnancy outcome 
Implantation rate per 
embryo (%) 
No. of children born 
Fresh Epididymal 
282 23 
2021 178 
1546 141 
927 76 
60 54 
258 21 
91 90 
38 4 
13 17 
7 2 
7.0 (45/649) 12.0 (6/47) 
10 3 
305 
2199 
1687 
1003 
60 
279 
91 
42 
14 
9 
7.3 (511696) 
13 
Viable pregnancies were ongoing or delivered at the time of writing. Biochem-
ical pregnancies were not included. 
Conclusions: Our results confirm that ICSI can be achieved 
successfully without using PVP. It now seems difficult to 
justify the injection of any potentially harmful agent into the 
oocyte during the ICSI procedure. 
Reference: 
Jean et a!. (1992) Ferti!' Steril., 57, 591-596. 
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Introduction: In various animal models hyperactivated motil-
ity is an essential property of capacitated spermatozoa and is 
characterized by the sudden appearance of a vigorous motion 
pattern. Several algorithms have been proposed to measure 
with computer-assisted sperm analysis (CAS A) the rate of 
hyperactivated motility of human spermatozoa. Whether the 
fertilizing failure of spermatozoa in IVF is caused by a lack 
of hyperactivated motility or by an unspecific inadequacy of 
sperm motion has yet to be studied. This study prospectively 
assessed the predictive value of six different algorithms of 
hyperactivated motility together with the percentile values of 
single motion parameters for the fertilization rate of cumulus-
enclosed human oocytes in vitro. 
Materials and methods: A total of 169 couples treated with 
conventional IVF were selected for this prospective study. The 
median curvilinear velocity (VCL) of the swim-up spermatozoa 
was measured with CASA. The number of washed spermatozoa 
inseminated into each oocyte in 0.1 ml culture medium was 
based on VCL. In those samples displaying a low median 
VCL value it was predicted that fertilization would not take 
place and high numbers of spermatozoa (200 000/0.1 ml) were 
inseminated. In those with high median VCL values the 
fertilization of three oocytes was predicted and fewer spermato-
zoa were inseminated (16000/0.1 ml). Based on the results of 
IVF the true-positive (88 couples, 52.1 %) and true-negative 
(20 couples, 11.8%) rates of the prediction were calculated. 
Results: The sensitivity of the prediction of IVF with CAS A 
was 92% and the specificity was 24%. Six different published 
algorithms describing hyperactive motility were applied to the 
CAS A data of the true-positive and true-negative patient 
groups. All six resulted in statistically significantly higher 
hyperactivity rates in the true-positive group. In addition, three 
single-motion parameters [VCL, lateral head displacement 
(ALH) and linearity (LIN)] permitted distinction between the 
samples with high and low fertilization rates. To screen for 
cut-off values distinguishing between both patient groups, the 
data for all motion parameters were split into percentile values: 
at all percentile levels the values of VCL, ALH and LIN were 
significantly different between the groups, and no distinctive 
cut-off value was identified. 
Conclusion: Fertilization failure in IVF is caused rather by a 
more general and unspecific disturbance of sperm motion than 
by just a lack of hyperactivated motility. 
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Introduction: The variability of ovarian response during 
stimulation by gonadotrophins in IVF protocols is one of the 
main difficulties encountered in assisted reproduction, despite 
the use of GnRH agonists. Ovarian status, explored by basal 
FSH concentration, is one of the explanations for this variabil-
ity. It has also been suggested that the plasma concentration 
of FSH could vary from one patient to another undergoing the 
same stimulation by gonadotrophins and that this could be 
used as a predictive test of oestradiol response in patients 
undergoing an IVF treatment following desensitization by 
GnRH agonists using a long-term protocol. 
Materials and methods: A total of 23 patients with a normal 
basal FSH concentration (range 2.3-7.8) were stimulated with 
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either HMG or highly purified FSH following a 20 day-long 
desensitization by either a single injection of 3 mg triptorelin 
or daily s.c. injections of 0.1 mg triptorelin. Ovarian desensit-
ization was assessed on day 1 by a serum oestradiol concentra-
tion <50 pg/ml. Patients received 2.0, 2.5, 3.0, 3.5 or 4.0 
ampoules/day during the first 4 days, according to the expected 
stimulation response. The dose of hormone was adapted on 
stimulation day 5 and subsequent days, according to the serum 
oestradiol concentration and, when necessary, to the vaginal 
sonography. Serum FSH concentrations were assessed simul-
taneously with oestradiol up to the day of ovulation induction 
by 10 000 IV HCG. Patients were classified into three groups 
according to the oestradiol response: group 1 (high response), 
when the serum oestradiol concentration curve exceeded the 
90th percentile; group 2 (medium response), when the curve 
remained between the 100th and the 90th percentile; and group 
3 (low response), when the curve remained below the 10th 
percentile. 
Results: We first studied the variation of FSH alter 4 days of 
stimulation (dFSH DI-D5). We found a significant linear 
correlation between FSH D I-D5 and the dose of gonadotrophin 
administered (r = 0.42, P < 0.02). This variation was not 
correlated (r = -0.3, not significant) to the body mass index 
[= weight (kg)/height2 (m2)], but our population was small 
and showed a narrow distribution of BMI (range 17.9-26.2). 
There was no difference either between the HMG and high 
purity FSH groups, or between the 3 mg triptorelin and 0.1 
mg triptorelin groups. More interesting, dFSH DI-D5 was the 
same, according to the dose of gonadotrophin administered, 
whether or not the oestradiol response was in group 1, 2 or 3; 
oestradiol response was not predictable in our population by 
dFSH DI-D5. Next we analysed the profile of serum FSH 
concentration throughout the stimulation: FSH concentration 
reached a plateau at day 5, the value of which was correlated 
with the dose of gonadotrophin administered; however the 
area under the curve did not differ significantly between groups 
1, 2 and 3. One interesting characteristic of FSH concentration 
was the rapid decline when gonadotrophin administration was 
discontinued: the day after HCG injection, mean decline was 
31.6 ± 15.7% and was not dependent on either BMI or the 
dose of gonadotrophin administered on the last days of 
stimulation. 
Discussion and conclusion: The exogenous administration of 
FSH to ovary-desensitized women leads, after 4 days, to a dose-
dependent serum FSH concentration which is not predictive of 
ovarian oestradiol response throughout stimulation. Moreover, 
women with radically different profiles of oestradiol response 
(groups 1,2 and 3), but with normal basal FSH concentrations, 
show similar profiles of FSH evolution throughout stimulation. 
As oestradiol secretion reflects ovarian response to stimulation, 
we may conclude from this observation that an explanation 
for its variability among women undergoing IVF treatment 
does not lie in a different metabolism of FSH but in the 
variability of ovarian and follicular sensitivity to circulating 
FSH. 
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